Idenix, Janssen work on hepatitis C treatments

01/31/2013 | Pharmaceutical Business Review Online

Janssen Pharmaceuticals and Idenix Pharmaceuticals are working together on clinical development of direct-acting antiviral combination treatments for hepatitis C virus. The collaboration covers a drug-drug interaction study, followed by a midstage trial. The trials will be conducted by Idenix.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL